Poster Presentation Title : A Phase Ib/II Multicenter, Randomized, Double Blind, Placebo-Controlled, Ascending Dose Finding Study of BXCL501 in Agitation Associated with Dementia Date/Time: May 30, ...

RVL Pharmaceuticals announced today that its prescription eye drop, Upneeq® (oxymetazoline hydrochloride ophthalmic solution) ...

Since their introduction over five decades ago, beta-blockers have revolutionized the landscape of cardiovascular medicine.

At the recent SEC meeting for Cardiovascular held on 23rd April 2024, the expert panel reviewed the proposal for the BE study ...

Premature ejaculation (PE), the blink-and-you’ll-miss-it hiccup of the bedroom, is like that uninvited guest crashing the party of your romantic rendezvous. With prevalence rates soaring up to 75 ...

This result was surprising because previously xylazine was thought to only bind to the α 2-adrenergic receptor, and this finding could hint as to why withdrawal from fentanyl in combination with ...

The crystal structure of a second G protein–coupled receptor sheds light on these key pharmaceutical targets. In contrast, β2AR and essentially all of the other GPCRs are present at very low ...

Among 351,297 Swedish men in the Stockholm PSA and Biopsy registry, 39,856 (11.3%) had filled at least 2 prescriptions for an alpha-1 adrenergic receptor antagonist. Over a median follow-up of 8.9 ...

Only the group of patients receiving beta-adrenergic blocking therapy before the event did not show an increased morning incidence of myocardial infarction. This observation may contribute to an ...

2 In this study, we describe novel interactions between adrenergic receptor (AR) and TH signaling regulating thermogenesis, cardiomyocyte proliferation, and heart regeneration. Collectively, our ...